Silence Therapeutics plc Weighted Average Shares
Silence Therapeutics plc (SLN) reported Weighted Average Shares of 111.28 million shares for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageShares · last filed 2024-03-13
| Period end | Weighted Average Shares 12 month |
|---|---|
| 2023-12-31 | 111.28M shares 20-F · filed 2024-03-13 |
| 2022-12-31 | 96.58M shares 20-F · filed 2024-03-13 |
| 2021-12-31 | 88.95M shares 20-F · filed 2024-03-13 |
| 2020-12-31 | 81.77M shares 20-F · filed 2023-03-15 |
| 2019-12-31 | 75.13M shares 20-F · filed 2022-03-17 |
| 2018-12-31 | 70.31M shares 20-F/A · filed 2021-04-29 |